Recent advances in neuroimaging in autism

Neuropsychiatry

Volumn 2, Issue 3, 2012, Pages 221-229

  Horder, Jamie ^a   Murphy, Declan G ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; GLUTAMIC ACID; GLUTAMINE; N ACETYLASPARTIC ACID;

AMYGDALOID NUCLEUS; ANTERIOR CINGULATE; AUTISM; BOLD SIGNAL; BRAIN MATURATION; BRAIN METABOLISM; BRAIN REGION; BRAIN SIZE; COMMUNICATION SKILL; CORPUS STRIATUM; DIFFUSION TENSOR IMAGING; FRONTAL LOBE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GRAY MATTER; HIPPOCAMPUS; HUMAN; NEUROANATOMY; NEUROBIOLOGY; NEUROCHEMISTRY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARIETAL LOBE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SOCIAL INTERACTION; TASK PERFORMANCE; WHITE MATTER;

EID: 84876511962     PISSN: 17582008     EISSN: 17582016     Source Type: Journal    
DOI: 10.2217/npy.12.25     Document Type: Review

References (86)

1. Brugha TS, McManus S, Bankart J et al. Epidemiology of autism spectrum disorders in adults in the community in England. Arch. Gen. Psychiatry 68(5), 459-465 (2011).
2. Maenner MJ, Durkin MS. Trends in the prevalence of autism on the basis of special education data. Pediatrics 126(5), e1018-e1025 (2010).
3. Geschwind DH. Advances in autism. Annu. Rev. Med. 60, 367-380 (2009).
4. Robinson EB, Koenen KC, McCormick MC et al. A multivariate twin study of autistic traits in 12-year-olds: testing the fractionable autism triad hypothesis. Behav. Genet. 42(2), 245-255 (2012).
5. Rutter M. Cognitive deficits in the pathogenesis of autism. J. Child Psychol. Psychiatry 24(4), 513-531 (1983).
6. Sharma S, Woolfson LM, Hunter SC. Confusion and inconsistency in diagnosis of Asperger syndrome: a review of studies from 1981 to 2010. Autism doi:10.1177/1362361311411935 (2011) (Epub ahead of print).
7. Wing L, Gould J, Gillberg C. Autism spectrum disorders in the DSM-V: better or worse than the DSM-IV? Res. Dev. Disabil. doi:10.1016/j.ridd.2010.11. 003 (2011) (Epub ahead of print).
8. Ronald A, Hoekstra RA. Autism spectrum disorders and autistic traits: A decade of new twin studies. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 156B(3), 255-274 (2011).
9. Gardener H, Spiegelman D, Buka SL. Perinatal and neonatal risk factors for autism: a comprehensive meta-analysis. Pediatrics 128(2), 344-355 (2011).
10. Whitehouse AJ, Coon H, Miller J, Salisbury B, Bishop D. Narrowing the broader autism phenotype: a study using the Communication Checklist - Adult Version (CC-A). Autism 14(6), 559-574 (2010).
11. Stanfield AC, McIntosh AM, Spencer MD, Philip R, Gaur S, Lawrie SM. Towards a neuroanatomy of autism: a systematic review and meta-analysis of structural magnetic resonance imaging studies. Eur. Psychiatry 23(4), 289-299 (2008).
12. Courchesne E, Hesselink JR, Jernigan TL, Yeung-Courchesne R. Abnormal neuroanatomy in a nonretarded person with autism. Unusual findings with magnetic resonance imaging. Arch. Neurol. 44(3), 335-341 (1987).
13. Garber HJ, Ritvo ER, Chiu LC et al. A magnetic resonance imaging study of autism: normal fourth ventricle size and absence of pathology. Am. J. Psychiatry 146(4), 532-534 (1989).
14. Jones PB, Kerwin RW. Left temporal lobe damage in Asperger's syndrome. Br. J. Psychiatry 156, 570-572 (1990).
15. Berthier ML, Starkstein SE, Leiguarda R. Developmental cortical anomalies in Asperger's syndrome: neuroradiological findings in two patients. J. Neuropsychiatry Clin. Neurosci. 2(2), 197-201 (1990).
16. Nowell MA, Hackney DB, Muraki AS, Coleman M. Varied MR appearance of autism: fifty-three pediatric patients having the full autistic syndrome. Magn. Reson. Imaging 8(6), 811-816 (1990). An early study of 53 autistic children using structural MRI, finding various abnormalities in some cases but with no consistent pattern.
17. Rumsey JM, Duara R, Grady C et al. Brain metabolism in autism. Resting cerebral glucose utilization rates as measured with positron emission tomography. Arch. Gen. Psychiatry 42(5), 448-455 (1985).
18. Herold S, Frackowiak RS, Le Couteur A, Rutter M, Howlin P. Cerebral blood flow and metabolism of oxygen and glucose in young autistic adults. Psychol. Med. 18(4), 823-831 (1988).
19. Haznedar MM, Buchsbaum MS, Metzger M, Solimando A, Spiegel-Cohen J, Hollander E. Anterior cingulate gyrus volume and glucose metabolism in autistic disorder. Am. J. Psychiatry 154(8), 1047-1050 (1997).
20. Clifford S, Dissanayake C, Bui QM, Huggins R, Taylor AK, Loesch DZ. Autism spectrum phenotype in males and females with fragile X full mutation and premutation. J. Autism Dev. Disord. 37(4), 738-747 (2007).
21. Percy AK. Rett syndrome: exploring the autism link. Arch. Neurol. 68(8), 985-989 (2011).
22. van der Graaf M. In vivo magnetic resonance spectroscopy: basic methodology and clinical applications. Eur. Biophys. J. 39(4), 527-540 (2010).
23. Shinohe A, Hashimoto K, Nakamura K et al. Increased serum levels of glutamate in adult patients with autism. Prog. Neuropsychopharmacol. Biol. Psychiatry 30(8), 1472-1477 (2006).
24. Wang LW, Berry-Kravis E, Hagerman RJ. Fragile X: leading the way for targeted treatments in autism. Neurotherapeutics 7(3), 264-274 (2010).
25. DeVito TJ, Drost DJ, Neufeld RW et al. Evidence for cortical dysfunction in autism: a proton magnetic resonance spectroscopic imaging study. Biol. Psychiatry 61(4), 465-473 (2007).
26. Hardan AY, Minshew NJ, Melhem NM et al. An MRI and proton spectroscopy study of the thalamus in children with autism. Psychiatry Res. 163(2), 97-105 (2008).
27. Friedman SD, Shaw DW, Artru AA et al. Regional brain chemical alterations in young children with autism spectrum disorder. Neurology 60(1), 100-107 (2003).
28. Page LA, Daly E, Schmitz N et al. In vivo 1H-magnetic resonance spectroscopy study of amygdala-hippocampal and parietal regions in autism. Am. J. Psychiatry 163(12), 2189-2192 (2006).
29. Bernardi S, Anagnostou E, Shen J et al. In vivo (1)H-magnetic resonance spectroscopy study of the attentional networks in autism. Brain Res. 1380, 198-205 (2011).
30. Rossignol DA, Frye RE. Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis. Mol. Psychiatry 17(3), 290-314 (2012).
31. Corrigan NM, Shaw DW, Richards TL et al. Proton magnetic resonance spectroscopy and MRI reveal no evidence for brain mitochondrial dysfunction in children with autism spectrum disorder. J. Autism Dev. Disord. 42(1), 105-115 (2012).
32. Friston KJ, Jezzard P, Turner R. Analysis of functional MRI time-series. Hum. Brain Mapping 1(2), 153-171 (1994).
33. Baron-Cohen S, Ring HA, Wheelwright S et al. Social intelligence in the normal and autistic brain: an fMRI study. Eur. J. Neurosci. 11(6), 1891-1898 (1999).
34. Spencer M, Holt RJ, Chura LR. A novel functional brain imaging endophenotype of autism: the neural response to facial expression of emotion. Translational Psychiatry doi:10.1038/tp.2011.18 (2011) (Epub ahead of print). Functional MRI was used to measure the neural activation response to seeing pictures of faces expressing emotion. The response was weakened both in people with autism spectrum disorders (ASDs), and their unaffected first-degree relatives, compared with controls.
35. Bolte S, Hubl D, Dierks T, Holtmann M, Poustka F. An fMRI-study of locally oriented perception in autism: altered early visual processing of the block design test. J. Neural Transm. 115(3), 545-552 (2008).
36. Dapretto M, Davies MS, Pfeifer JH et al. Understanding emotions in others: mirror neuron dysfunction in children with autism spectrum disorders. Nat. Neurosci. 9(1), 28-30 (2006).
37. Dinstein I, Thomas C, Behrmann M, Heeger DJ. A mirror up to nature. Curr. Biol. 18(1), R13-R18 (2008).
38. Klin A. Three things to remember if you are a functional magnetic resonance imaging researcher of face processing in autism spectrum disorders. Biol. Psychiatry 64(7), 549-551 (2008).
39. Orru G, Pettersson-Yeo W, Marquand AF, Sartori G, Mechelli A. Using Support Vector Machine to identify imaging biomarkers of neurological and psychiatric disease: a critical review. Neurosci. Biobehav. Rev. 36(4), 1140-1152 (2012).
40. Ecker C, Marquand A, Mourao-Miranda J et al. Describing the brain in autism in five dimensions - magnetic resonance imaging-assisted diagnosis of autism spectrum disorder using a multiparameter classification approach. J. Neurosci. 30(32), 10612-10623 (2010).Multivariate pattern analysis of brain structural MRI was able to distinguish brains of adults with ASDs from healthy controls and from individuals with attention-deficit hyperactivity disorder.
41. D'Hulst C, Kooy RF. Fragile X syndrome: from molecular genetics to therapy. J. Med. Genet. 46(9), 577-584 (2009).
42. Hoeft F, Walter E, Lightbody AA et al. Neuroanatomical differences in toddler boys with fragile X syndrome and idiopathic autism. Arch. Gen. Psychiatry 68(3), 295-305 (2011).
43. Brock J, Brown CC, Boucher J, Rippon G. The temporal binding deficit hypothesis of autism. Dev. Psychopathol. 14(2), 209-224 (2002).
44. Groen WB, Buitelaar JK, van der Gaag RJ, Zwiers MP. Pervasive microstructural abnormalities in autism: a DTI study. J. Psychiatry Neurosci. 36(1), 32-40 (2011).
45. Lange N, Dubray MB, Lee JE et al. Atypical diffusion tensor hemispheric asymmetry in autism. Autism Res. 3(6), 350-358 (2010).
46. Shukla DK, Keehn B, Muller RA. Tract-specific analyses of diffusion tensor imaging show widespread white matter compromise in autism spectrum disorder. J. Child Psychol. Psychiatry 52(3), 286-295 (2011).
47. Langen M, Leemans A, Johnston P et al. Fronto-striatal circuitry and inhibitory control in autism: Findings from diffusion tensor imaging tractography. Cortex 48(2), 183-193 (2012).
48. Mengotti P, D'Agostini S, Terlevic R et al. Altered white matter integrity and development in children with autism: a combined voxel-based morphometry and diffusion imaging study. Brain Res. Bull. 84(2), 189-195 (2011).
49. Cheng Y, Chou KH, Chen IY, Fan YT, Decety J, Lin CP. Atypical development of white matter microstructure in adolescents with autism spectrum disorders. Neuroimage 50(3), 873-882 (2010).
50. Fox MD, Raichle ME. Spontaneous fluctuations in brain activity observed with functional magnetic resonance imaging. Nat. Rev. Neurosci. 8(9), 700-711 (2007).
51. Lai MC, Lombardo MV, Chakrabarti B et al. A shift to randomness of brain oscillations in people with autism. Biol. Psychiatry 68(12), 1092-1099 (2010).
52. Cherkassky VL, Kana RK, Keller TA, Just MA. Functional connectivity in a baseline resting-state network in autism. Neuroreport 17(16), 1687-1690 (2006).
53. Anderson JS, Druzgal TJ, Froehlich A et al. Decreased interhemispheric functional connectivity in autism. Cereb. Cortex 21(5), 1134-1146 (2010).
54. Anderson JS, Nielsen JA, Froehlich AL et al. Functional connectivity magnetic resonance imaging classification of autism. Brain 134(Pt 12), 3742-3754 (2011). In this study, multivariate analysis of patterns of neural activity in the brain at rest (resting state functional connectivity MRI) revealed abnormalities in ASD.
55. Barttfeld P, Wicker B, Cukier S, Navarta S, Lew S, Sigman M. A big-world network in ASD: Dynamical connectivity analysis reflects a deficit in long-range connections and an excess of short-range connections. Neuropsychologia 49(2), 254-263 (2011).
56. Kanner L. Autistic disturbances of affective contact. Nerv. Child 2, 217-250 (1943).
57. Hazlett HC, Poe MD, Gerig G et al. Early brain overgrowth in autism associated with an increase in cortical surface area before age 2 years. Arch. Gen. Psychiatry 68(5), 467-476 (2011).
58. Verhoeven JS, De Cock P, Lagae L, Sunaert S. Neuroimaging of autism. Neuroradiology 52(1), 3-14 (2010).
59. Stigler KA, McDonald BC, Anand A, Saykin AJ, McDougle CJ. Structural and functional magnetic resonance imaging of autism spectrum disorders. Brain Res. 1380, 146-161 (2011).
60. Amaral DG, Schumann CM, Nordahl CW. Neuroanatomy of autism. Trends Neurosci. 31(3), 137-145 (2008).
61. Chen R, Jiao Y, Herskovits EH. Structural MRI in autism spectrum disorder. Pediatr. Res. 69(5 Pt 2), 63R-68R (2011).
62. Geschwind DH, Levitt P. Autism spectrum disorders: developmental disconnection syndromes. Curr. Opin. Neurobiol. 17(1), 103-111 (2007).
63. Yu KK, Cheung C, Chua SE, McAlonan GM. Can Asperger syndrome be distinguished from autism? An anatomic likelihood meta-analysis of MRI studies. J. Psychiatry Neurosci. 36(6), 412-421 (2011).
64. Freitag CM, Staal W, Klauck SM, Duketis E, Waltes R. Genetics of autistic disorders: review and clinical implications. Eur. Child Adolesc. Psychiatry 19(3), 169-178 (2010).
65. Schaaf CP, Zoghbi HY. Solving the autism puzzle a few pieces at a time. Neuron 70(5), 806-808 (2011).
66. Shen Y, Chen X, Wang L et al. Intra-family phenotypic heterogeneity of 16p11.2 deletion carriers in a three-generation Chinese family. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 156(2), 225-232 (2011).
67. Moreno-De-Luca D, Mulle JG, Kaminsky EB et al. Deletion 17q12 is a recurrent copy number variant that confers high risk of autism and schizophrenia. Am. J. Hum. Genet. 87(5), 618-630 (2010).
68. Heger M. Genetic insights beginning to divide autism diagnosis. Nat. Med. 17(4), 398 (2011). Discussion of the significance of new genetic findings in ASD and the potential for a new, genetically informed approach to ASD diagnosis.
69. Kortum F, Das S, Flindt M et al. The core FOXG1 syndrome phenotype consists of postnatal microcephaly, severe mental retardation, absent language, dyskinesia, and corpus callosum hypogenesis. J. Med. Genet. 48(6), 396-406 (2011).
70. Wegiel J, Schanen NC, Cook EH et al. Differences between the pattern of developmental abnormalities in autism associated with duplications 15q11.2-q13 and idiopathic autism. J. Neuropathol. Exp. Neurol. 71(5), 382-397 (2012).
71. Howes OD, Kapur S. The dopamine hypothesis of schizophrenia: version III - the final common pathway. Schizophr. Bull. 35(3), 549-562 (2009).
72. Hogart A, Nagarajan RP, Patzel KA, Yasui DH, Lasalle JM. 15q11-13 GABAA receptor genes are normally biallelically expressed in brain yet are subject to epigenetic dysregulation in autism-spectrum disorders. Hum. Mol. Genet. 16(6), 691-703 (2007).
73. Lingford-Hughes A, Reid AG, Myers J et al. A [11c]Ro15 4513 PET study suggests that alcohol dependence in man is associated with reduced {alpha}5 benzodiazepine receptors in limbic regions. J. Psychopharmacol. 26(2), 273-281 (2012).
74. Mendez MA, Horder J, Myers J et al. The brain GABA-benzodiazepine receptor alpha-5 subtype in autism spectrum disorder: A pilot [11C]Ro15-4513 positron emission tomography study. Neuropharmacology (2012) (In press).
75. Mu L, Schubiger PA, Ametamey SM. Radioligands for the PET imaging of metabotropic glutamate receptor subtype 5 (mGluR5). Curr. Top Med. Chem. 10(15), 1558-1568 (2010).
76. Gogolla N, Leblanc JJ, Quast KB, Sudhof T, Fagiolini M, Hensch TK. Common circuit defect of excitatory-inhibitory balance in mouse models of autism. J. Neurodev. Disord. 1(2), 172-181 (2009).
77. Pizzarelli R, Cherubini E. Alterations of GABAergic signaling in autism spectrum disorders. Neural Plast. 2011, 297153 (2011).
78. Polders DL, Leemans A, Hendrikse J, Donahue MJ, Luijten PR, Hoogduin JM. Signal to noise ratio and uncertainty in diffusion tensor imaging at 1.5, 3.0, and 7.0 Tesla. J. Magn. Reson. Imaging 33(6), 1456-1463 (2011).
79. Bode S, He AH, Soon CS, Trampel R, Turner R, Haynes JD. Tracking the unconscious generation of free decisions using uitra-high field fMRI. PLoS ONE 6(6), e21612 (2011).
80. Bandettini PA, Bowtell R, Jezzard P, Turner R. Ultrahigh field systems and applications at 7 T and beyond: progress, pitfalls, and potential. Magn. Reson. Med. 67(2), 317-321 (2012).
81. Stevenson JL, Kellett KA. Can magnetic resonance imaging aid diagnosis of the autism spectrum? J. Neurosci. 30(50), 16763-16765 (2010).
82. Walsh P, Elsabbagh M, Bolton P, Singh I. In search of biomarkers for autism: scientific, social and ethical challenges. Nat. Rev. Neurosci. 12(10), 603-612 (2011). Discusses the ethical and practical considerations raised by the possibility of neuroimaging-aided diagnosis of ASD.
83. Murphy DG, Beecham J, Craig M, Ecker C. Autism in adults. New biologicial findings and their translational implications to the cost of clinical services. Brain Res. 1380, 22-33 (2011).
84. Nygren G, Cederlund M, Sandberg E et al. The prevalence of autism spectrum disorders in toddlers: a population study of 2-year-old Swedish children. J. Autism Dev. Disord. doi:10.1007/s10803-011-1391-x (2011) (Epub ahead of print).
85. Wittchen HU, Jacobi F, Rehm J et al. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur. Neuropsychopharmacol. 21(9), 655-679 (2011).
86. Campbell M, Reynolds L, Cunningham J, Minnis H, Gillberg CG. Autism in Glasgow: cumulative incidence and the effects of referral age, deprivation and geographical location. Child Care Health Dev. doi:10.1111/j.1365-2214.2011. 01340.x (2011) (Epub ahead of print).